Semaglutide for T2s

The European Medicines Agency’s human medicines committee (CHMP) has recommended granting a marketing authorization in the EU for Rybelsus (semaglutide) for the treatment of adults

Read More »

New Type 2 treatment

A breakthrough treatment for Type 2 diabetes is now available to self-paying patients at The Princess Grace Hospital in London. Revita is a minimally invasive procedure

Read More »

Rotavirus and Type 1?

Researchers from the University of Melbourne suggest that the rotavirus infection could be linked to triggering the onset of Type 1 diabetes. Vaccination programs in

Read More »